scispace - formally typeset
I

Ilona Golynker

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  10
Citations -  392

Ilona Golynker is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 4 publications receiving 97 citations.

Papers
More filters
Journal ArticleDOI

Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity.

TL;DR: In this paper, the authors investigated the dynamics of the systemic response to SARS-CoV-2 in hamsters by histological analysis and transcriptional profiling, and they found that the antiviral response with intranasal administration of recombinant IFN-I reduced viral disease, prevented transmission, and lowered inflammation in vivo.
Journal ArticleDOI

SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery

TL;DR: Compared the short- and long-term systemic responses in the golden hamster following either SARS-CoV-2 or influenza A virus (IAV) infection, data highlight a molecular mechanism for persistent COVID-19 symptomology and provide a small animal model to explore future therapeutics.
Posted ContentDOI

SARS-CoV-2 infection results in lasting and systemic perturbations post recovery

TL;DR: Compared the short- and long-term systemic responses in the golden hamster following either SARS-CoV-2 or influenza A virus infection are compared to highlight a molecular mechanism for persistent COVID-19 symptomology and characterize a small animal model to develop future therapeutics.
Journal ArticleDOI

A Molecular Basis of Long COVID-19

TL;DR: The most significant change in response to SARS-CoV-2 was observed in the olfactory bulb, where persistent inflammation was visible beyond one month post infection, and it is postulated that this prolonged inflammation is an underlying cause of long COVID.